Expertise

Salmeterol / Fluticasone

CCDRD AG has extensive experience with generic Salmeterol/Fluticasone inhalation product development compared to the available DPI and MDI reference products.

  • 25 trials performed with Salmeterol/Fluticasone DPI and MDI inhalers in healthy subjects
  • systemic safety and pulmonary deposition studies
  • highly experienced investigators and study teams in the phase I units available
  • standardized training and clinical procedures
  • intrasubject and residual variance data available
  • information about product aging available